StockData
GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP) stock

GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.43+0.25 (+7.86%)

Close on Nov 18, 2026Market cap $154.73MP/E –Yield –

GT Biopharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

GT Biopharma's revenue for the twelve months ending Sep 30, 2021 was $0. For fiscal 2020 it was $0. The highest annual figure on record is $368.00K in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2020Dec 31, 2020$0–
FY2019Dec 31, 2019$0–
FY2017Dec 31, 2017$0–
FY2016Dec 31, 2016$0-100.0%
FY2015Dec 31, 2015$27.00K-55.7%
FY2014Dec 31, 2014$61.00K-83.4%
FY2013Dec 31, 2013$368.00K+7.6%
FY2012Dec 31, 2012$342.00K+1215.4%
FY2011Dec 31, 2011$26.00K+136.4%
FY2010Dec 31, 2010$11.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2021Sep 30, 2021$0–
Q2 FY2021Jun 30, 2021$0–
Q1 FY2021Mar 31, 2021$0–
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–
Q1 FY2020Mar 31, 2020$0–
Q1 FY2019Mar 31, 2019$0–
Q2 FY2018Jun 30, 2018$0–
Q1 FY2018Mar 31, 2018$0–
Q4 FY2017Dec 31, 2017$0–
Q3 FY2017Sep 30, 2017$0–
Q2 FY2017Jun 30, 2017$0–
Q1 FY2017Mar 31, 2017$0–
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–

More GT Biopharma figures

See a number that looks wrong?